文献速递肿瘤 PET/CT

长轴视野PET/CT联合低剂量[18F]FDG在黑色素瘤中的应用

Application of the long axial field-of-view PET/CT with low-dose [18F]FDG in melanoma.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2022-12-07

研究纳入49例黑色素瘤患者,评估长轴视野Biograph Vision Quadra PET/CT在静脉注射2.0 MBq/kg [18F]FDG后不同采集时间(2至8分钟)的图像质量,以10分钟采集(PET-10)为参考。视觉分析显示PET-8和PET-6与PET-10病理检出率均为49/60(81.7%),病灶检出率PET-8为97.5%、PET-6为95.0%、PET-5为89.9%、PET-4为83.2%、PET-2为73.9%。作者结论为低剂量长轴视野PET/CT可行,头部至大腿上段总扫描时间可缩短至5分钟并提供与标准采集时长相当的诊断数据。

要点

  • 视觉分析中PET-8和PET-6病理检出率均为49/60(81.7%),与PET-10相同。
  • 病灶检出率PET-8为97.5%(116/119)、PET-6为95.0%(113/119)、PET-5为89.9%(107/119)。
  • 作者结论:头部至大腿上段扫描时间可缩短至5分钟,提供与标准采集时长相当的诊断数据。

核心结论

  • 在黑色素瘤中,低剂量长轴视野PET/CT显像可行,头部至大腿上段总扫描时间可缩短至5分钟,提供与标准采集时长相当的诊断数据。

研究设计与样本

  • 研究纳入49例黑色素瘤患者,所有患者静脉注射2.0 MBq/kg [18F]FDG后行头部至足部全身PET/CT,两个床位数(视野106 cm)。
  • 第一床位(头部至大腿上段;PET-10)图像重建后进一步分为8分钟(PET-8)、6分钟(PET-6)、5分钟(PET-5)、4分钟(PET-4)和2分钟(PET-2)时长组。
  • 以PET-10图像为参考进行视觉评价比较,并计算不同采集时间差异的95%CI。
  • 基于肿瘤病灶和本底SUV计算肝脏信噪比(SNR)和肿瘤-本底比(TBR)进行客观图像质量评价。

主要发现

  • 共评估60次扫描;视觉分析中PET-10病理扫描为49/60(81.7%),PET-8为49/60(81.7%,95%CI:-0.0602至0.0602),PET-6为49/60(81.7%,95%CI:-0.0602至0.0602)。
  • 视觉分析中PET-5病理扫描为48/60(80%,95%CI:-0.0445至0.0886),PET-4为46/60(76.7%,95%CI:-0.0132至0.1370),PET-2为45/60(75%,95%CI:0.0025至0.1593)。
  • 18次PET-10扫描转移累及范围很大,难以准确计算[18F]FDG高摄取肿瘤病灶;其余42次PET-10扫描可准确计算肿瘤病灶,共计数119个肿瘤病灶。
  • 病灶检出率:PET-8为97.5%(116/119,95%CI:0至1),PET-6为95.0%(113/119,95%CI:0至1),PET-5为89.9%(107/119,95%CI:0至2)。
  • 病灶检出率:PET-4为83.2%(99/119,95%CI:1至2),PET-2为73.9%(88/119,95%CI:2至4)。

临床怎么用

  • 作者结论认为在黑色素瘤中低剂量长轴视野PET/CT显像可行,头部至大腿上段总扫描时间可缩短至5分钟,提供与标准采集时长相当的诊断数据,鉴于该类癌症需要真正全身显像,这可能对黑色素瘤患者的诊断检查有重要意义。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: The recent introduction of long axial field-of-view (LAFOV) PET/CT scanners has yielded very promising results regarding image quality and sensitivity in oncological patients. We, herein, aim to determine an appropriate acquisition time range for the new long axial field of view Biograph Vision Quadra PET/CT (Siemens Healthcare) using low dose [18F]FDG activity in a group of melanoma patients. METHODOLOGY: Forty-nine melanoma patients were enrolled in the study. All patients underwent total body PET/CT from the top of the head through the feet in two bed positions (field-of-view 106 cm) after i.v. injection of 2.0 MBq/kg [18F]FDG. The PET images of the first bed position (head to upper thigh; PET-10) were reconstructed and further split into 8-min (PET-8), 6-min (PET-6), 5-min (PET-5), 4-min (PET-4), and 2-min (PET-2) duration groups. Comparisons were performed between the different reconstructed scan times with regard to the visual evaluation of the PET/CT scans using the PET-10 images as reference and by calculating the 95%-CI for the differences between different time acquisitions. Moreover, objective evaluation of PET/CT image quality was performed based on SUV calculations of tumor lesions and background, leading to calculation of liver signal-to-noise ratio (SNR), and tumor-to-background ratio (TBR). RESULTS: A total of 60 scans were evaluated. Concerning visual analysis, 49/60 (81.7%) PET-10 scans were pathological, while the respective frequencies were 49/60 (81.7%) for PET-8 (95%-CI: - 0.0602-0.0602), 49/60 (81.7%) for PET-6 (95%-CI: - 0.0602-0.0602), 48/60 (80%) for PET-5 (95%-CI: - 0.0445-0.0886), 46/60 (76.7%) for PET-4 (95%-CI: - 0.0132-0.1370), and 45/60 (75%) for PET-2 (95%-CI: 0.0025-0.1593). In 18 PET-10 scans, the extent of metastatic involvement was very large, rendering the accurate calculation of [18F]FDG-avid tumor lesions very complicated. In the remaining 42 PET-10 scans, for which the exact calculation of tumor lesions was feasible, a total of 119 tumor lesions were counted, and the respective lesion detection rates for shorter acquisitions were as follows: 97.5% (116/119) for PET-8 (95%-CI: 0-1), 95.0% (113/119) for PET-6 (95%-CI: 0-1), 89.9% (107/119) for PET-5 (95%-CI: 0-2), 83.2% (99/119) for PET-4 (95%-CI: 1-2), and 73.9% (88/119) for PET-2 (95%-CI: 2-4). With regard to objective image quality evaluations, as a general trend, the reduction of acquisition time was associated with a decrease of liver SNR and a decrease of TBR, although in lesion-based analysis the change in TBR and tumor SUVmean values was non-significant up to 6 and 5 min acquisitions, respectively. CONCLUSIONS: In melanoma, low-dose LAFOV PET/CT imaging is feasible and can reduce the total scan time from head to upper thigh up to 5 min providing comparable diagnostic data to standard lengths of acquisition. This may have significant implications for the diagnostic work-up of patients with melanoma, given the need for true whole-body imaging in this type of cancer.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Sachpekidis C, Pan L, Kopp-Schneider A, et al. Application of the long axial field-of-view PET/CT with low-dose [18F]FDG in melanoma. Eur J Nucl Med Mol Imaging. 2022. PMID: 36474125. doi:10.1007/s00259-022-06070-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。